August Edition 2026

Message from the CEO

Good afternoon,

We’re celebrating the five medtech device companies selected to receive funding and commercialisation support through our Targeted Translation Research Accelerator. It is an investment of $4.2 million in home-grown cardiovascular innovations from two companies in Western Australia and one each from South Australia, Victoria and New South Wales. Their innovations include an early test for deep vein thrombosis, a new approach to heart valve replacement, an AI-software platform for analysis of arterial disease, a pulse sensing device to improve CPR and paediatric vascular access technology for critical care. 

Congratulations to Corametix (WA), Kynetyka Technologies (SA), Navi Medical Technologies (VIC), Navier Medical (WA) and Pulsatile Innovations (NSW) - our team is looking forward to working with you and we can’t wait to see what you achieve in the coming years.   

The benefit of our accelerator programs is working with in-house specialists and industry partners giving them the best chances of building sovereign success to reach commercial proof-of-concept – and all with the backing of the Medical Research Future Fund.

With our ongoing focus on international markets and global supply chains, we are expanding our activities in China, one of the world's most dynamic and intriguing life sciences ecosystems.

Under our recently launched BioGateway China initiative and with backing from our MoU partner, the Shanghai Center of Biomedicine Development/Science and Technology Commission of the Shanghai Municipality, we’re excited to be taking a delegation of Australian life science innovators to Shanghai and Suzhou from 23-27 November this year.

With a two-track program, the mission is being tailored to cater for companies seeking ecosystem immersion (startups, researchers) or executive partnering (clinical trial associated organisations seeking commercial opportunities). It’s about providing companies with a unique entre to better understand China’s life sciences landscape, build meaningful connections and identify opportunities for growth.

If you're already active in China, or curious about the opportunities there, I'd encourage you to join the delegation – registrations are closing on 16 October 2026 with limited places, so don’t miss out. We held an information session recently to run through the details.

In other international news, we announced the Australian medtech delegation bound for Boston US later in October. And it’s a standout group including: Australis Scientific, !ProHeme Diagnostics, EMVision Medical Devices, Wavewise Analytics, Kynetyka Technologies Pty Ltd, Medical Technology Association of Australia (MTAA), Planet Innovation, Vysena Medical, Mobius Medical, Innovate Medtech, Invetech, Sleeptite and Exa Product Development.

The Team Australia mission, led by our Board Chair The Hon. Jaala Pulford, will be taking on Boston with a top-notch site visit program, an added stop in New York City for a pitch session with US investors, and co-exhibitor status on the Australian Pavilion for these companies who will be receiving support from AUScelerate’s on-the-ground concierge service.

And a reminder to mark your calendars for 14-16 December 2026 as BIO Middle East, the region’s premier biotechnology and life sciences event, launches in the thriving heart of Riyadh. Our trade mission and site visit program (13 December) is coming together and you can join us by registering.

In our podcast this month, meet Roam Technologies co-founders Natalie Ho and CEO ShanShan Wang – an award-winning Australian medtech startup developing JUNO, the world’s first tankless, portable oxygen device. They have been exploring the US market over the last few years and joined several AUScelerate US missions, and just wrapped up a stint at the Texas Medical Center HealthTech Accelerator. An inspirational startup success story!

We will be taking part in the 'Australia-China BioInnovation Roundtable' and the 'New Approach Methods in Australian Biotech forum', both official satellite events to AusBiotech’s ‘Biggest Week in Biotech’ conference in October on the Gold Coast. Both promise fascinating discussions and hope to see you there.   

Thank you connecting with us and you’ll find more details below about exciting events and opportunities coming up over the next few months.

Kind regards,

Stuart Dignam
Chief Executive Officer and Managing Director 

AUScelerate & Industry News

On World Heart Day, AUScelerate’s Targeted Translation Research Accelerator announced it's investing $4.2 million into five home grown medical devices for cardiovascular disease, and leveraging an additional $6.3 million in sector investment.

Congratulations to this diverse cohort: CoraMetix (WA), Kynetyka Technologies (SA), Navi Medical Technologies (VIC), Navier Medical (WA) and Pulsatile Innovations (NSW)

Building a Gateway to China
AUScelerate is expanding its international activities to China with our first mission to Shanghai and Suzhou and we’re delighted to be working with our MoU partners to make it a success. 

Join the BioGateway China program: China Life Sciences Ecosystem Immersion
Shanghai & Suzhou, 23-27 November 2026. Book your place by 16 October 2026. 

Introducing our Australian medtech delegation bound for Boston US

AUScelerate is proud to lead the Australian medtech delegation to The MedTech Conference, in Boston, 18–21 October 2026. It’s all about showcasing Australian medtech innovation on the world stage with a standout group of companies:

Australis Scientific, !ProHeme Diagnostics, EMVision Medical Devices, Wavewise Analytics, Kynetyka Technologies Pty Ltd, Medical Technology Association of Australia (MTAA), Planet Innovation, Vysena Medical, Mobius Medical, Innovate Medtech, Invetech, Sleeptite and Exa Product Development

WAGES Strategic Workshop - Building Your Research: Demonstrating Capability, Impact and Leadership - Opens Registrations
AUScelerate's half-day hybrid WAGES workshop, delivered in partnership with Maali Hub from the Our Collaboration in Health Research (OCHRe) Network, invites Expressions of Interest from Indigenous EMCRs and non-Indigenous EMCRs working in Aboriginal and Torres Strait Islander health research to participate in a career development workshop focused on building research capability, impact and leadership.  On 5 November, 8.45am-12pm AWST, in person (for WA participants) at Edith Cowan University, and online for participants based around Australia. Apply by 15 October 2026. 

On the AUScelerate Podcast this month, we meet ShanShan Wang and Natalie Ho – co founders of Roam Technologies – an Australian medtech startup behind JUNO – the world’s first tankless, portable oxygen device.

👏Congratulations to Lenexa Medical, part of AUScelerate's Pathway to Market program cohort, has been named among TIME’s World’s Top HealthTech Companies, for the second year running!

Oligonucleotide Therapeutics Regional Meeting-Australia & New Zealand

Calling all researchers, clinicians, and industry leaders! The inaugural Oligonucleotide Therapeutics Regional Meeting-Australia & New Zealand is coming to Perth in November.

📅 25–27 November 2026
📍 The Ritz-Carlton Perth, WA

Follow the conference on LinkedIn.

Sector Opportunities

• AUScelerate is proud to support BrainTech 2026 in Melbourne on 15 October 2026. Use our exclusive promo code BT26-FRIENDS and get 20% off the ticket price. Register
   

• Boson Ventures is hosting the 2026 Australia–China BioInnovation Roundtable on the Gold Coast. AUScelerate CEO Stuart Dignam will open the event with a scene setting session. Join this official satellite event of AusBiotech's Australia's Biggest Week in Biotech, on 19 October. Book your seat!
   

• MAITRI, an Australia–India Innovation & Investment Initiative led by the Deakin Small-to-Medium Enterprise Research Centre, is welcoming registrations for its upcoming online workshops, designed to support Australian SMEs in exploring market opportunities, partnerships, and investment pathways in India's fast-growing innovation ecosystem with a focus on AI, robotics, health technology, pharmaceuticals, and related innovation sectors. Learn more and register
   

• The National Foundation for Medical Research and Innovation (NFMRI) 50th Anniversary Grant. NFMRI will award a single grant of up to $1 million over a period of up to three years to an Australian Publicly Funded Research Organisation (PFRO) (e.g. University, MRI) with Deductible Gift Recipient (DGR) status. Closes 29 October 2026. Register

• AMGC has launched a new co-investment program, the SME Industrial Decarbonisation Fund, supporting SME manufacturers to transition from fossil fuel-powered processes to electrified alternatives - find out more 
   

• CBE's Translation Uplift Program is offering a series of short courses covering the technical aspects of translating assets from research to commercial by giving you the tools and technical knowledge to take your understanding about translation to the next level. Enrol now.
   

• MedTech Navigator, delivered by MTAA in collaboration with Austrade, is a structured national capability-building and market access program designed for emerging and growth-stage MedTech SMEs that are preparing to expand beyond Australia. First cohort runs from Oct 2026 - May 2027. Apply
   

• Here is a tip - subscribe to gemaker's monthly newsletter to stay up to date on commercialisation, innovation and research news, plus jobs, funding, awards, events and more

Events​

• 15 October 2026 - Braintech 2026 (Melbourne)
• 14–21 October 2026 - The MedTech Conference (AdvaMed) (Boston)
• 19 October 2026 - Australia-China Bioinnovation Roundtable 2026, Boson Ventures (Gold Coast)
• 19 - 23 October 2026 - AusBiotech International Conference, AusBiotech (Gold Coast)
• 29 October 2026 - Innovation 2 Translation 2026, Melb Therapeutics (Melb)
• 11–18 November 2026 - HLTH Conference & US Delegation, ANDHealth (San Francisco & Las Vegas)
• 23–27 November 2026 - AUScelerate BioGateway China, AUScelerate (Shanghai, Suzhou)
• 25–27 November 2026 - Oligonucleotide Therapeutics Regional Meeting-Australia & NZ, (Perth)
• 2 December 2026 - APPLAUSE 2026, AUScelerate SA (Adelaide)
• 6–9 December 2026 - Australasian Pharmaceutical Science Association (APSA) 2026 Annual Conference, RMIT University (City Campus, Melbourne)
• 14–16 December 2026 - BIO Middle East (Riyadh, Saudi Arabia)
• 2–3 March 2027 - MTAA MedTech Conference 2027, MTAA (Sydney)
• 27–28 May 2027 - Women's Health Medtech Summit, MTAA (Sydney)
• 19–23 October 2027 - AusBiotech Conferences, AusBiotech (Gold Coast)

To see what events are coming up in 2026-2027, visit our news webpage and events webpage.

Case Study Showcase

Chronic disease prevention through the Culture and Kinship Model

A strength-based prevention approach based on Aboriginal Culture, Kinship, Community, and Country.

In this latest case study from our Targeted Translation Research Accelerator for diabetes and cardiovascular disease, find out why the Culture and Kinship model is promising to help address chronic disease prevention for Aboriginal and Torres Strait Islander people in Victoria by creating, strengthening, or restoring connections to Culture, Kinship, Community, and Country. The model has been developed by the Victorian Aboriginal Community Controlled Health Organisation (VACCHO), the peak representative body for Aboriginal and Torres Strait Islander health and wellbeing in Victoria and evaluated in partnership with KOWA Collaboration and Think Impact.

*Artwork above is by Rochelle Patten Snr (Qway),Gunnai, Yorta Yorta, Wemba Wemba, Dhudhuroa